Skip to main content
HCWB
NASDAQ Life Sciences

HCW Biologics Regains Full Rights to Two Commercial-Ready CAR-T Reagents for Free

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.7
Mkt Cap
$17.643M
52W Low
$0.25
52W High
$8.746
52W Position info
980% above low
Off High info
69% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

HCWB has more than doubled off its 52-week low of $0.25 on light trading volume (0.2× avg).

Summary

HCW Biologics has regained full ex vivo rights to two commercial-ready reagents, HCW9206 and HCW9201, from Wugen Inc. at no cost, retaining the original license fee and 2.2 million Wugen shares. This move positions the company to enter the multi-billion-dollar CAR-T immunotherapy market, with recent data suggesting HCW9206 can reduce CAR-T production costs and improve therapeutic efficacy. This strategic asset acquisition is a significant positive development for HCW Biologics, which has recently faced a going concern warning, Nasdaq delisting notice, and a highly dilutive $5.6 million offering. The company plans to commercialize these reagents through new corporate partnerships.

At the time of this announcement, HCWB was trading at $2.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $17.6M. The 52-week trading range was $0.25 to $8.75. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

HCWB - Latest Insights

HCWB
Nov 18, 2026, 5:24 PM EST
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.7639
Real-time Price: $0.7673 info
Change: +$0.0034 (+0.45%) info
Market Cap: $2.352M info
HCWB
Nov 16, 2026, 8:30 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.780
Real-time Price: $0.7673 info
Change: -$0.0127 (-2%) info
Market Cap: $2.352M info
HCWB
Nov 16, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.780
Real-time Price: $0.7673 info
Change: -$0.0127 (-2%) info
Market Cap: $2.352M info
HCWB
Nov 16, 2026, 8:15 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.780
Real-time Price: $0.7673 info
Change: -$0.0127 (-2%) info
Market Cap: $2.352M info
HCWB
Nov 05, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.09
Real-time Price: $0.7673 info
Change: -$0.3227 (-30%) info
Market Cap: $2.352M info